Table 1.
Total SCCA | SCCA1 | SCCA2 | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Donor | I | II | II | II | III | III | IV | V | VI | I | II | II | III | IV | V | VI | I | II | II | III | III | IV | V | VI | |
Normal PBMC Days of culture | 0 | − | − | − | n.d. | − | − | n.d. | − | n.d. | − | − | − | − | n.d. | − | − | − | − | − | − | − | n.d. | − | − |
1 d | + | + | + | n.d. | + | + | n.d. | n.d. | n.d. | + | − | − | + | n.d. | n.d. | n.d. | + | + | − | + | − | n.d. | n.d. | n.d. | |
1 d/PHA | + | + | + | n.d. | + | + | n.d. | + | + | + | − | − | − | n.d. | + | + | + | − | − | − | + | n.d. | + | + | |
2 d/PHA | + | + | + | n.d. | + | + | n.d. | n.d. | n.d. | + | + | − | − | n.d. | n.d. | n.d. | +/− | − | − | − | − | n.d. | n.d. | n.d. | |
3 d/PHA | + | + | + | n.d. | + | + | n.d. | n.d. | n.d. | + | − | + | − | n.d. | n.d. | n.d. | +/− | − | − | − | − | n.d. | n.d. | n.d. | |
4 d/PHA | + | + | + | n.d. | + | + | n.d. | n.d. | n.d. | − | − | − | − | n.d. | n.d. | n.d. | +/− | − | − | − | − | n.d. | n.d. | n.d. | |
5 d/PHA | + | + | − | + | − | + | n.d. | n.d. | n.d. | − | − | − | − | n.d. | n.d. | n.d. | +/− | − | − | − | − | n.d. | n.d. | n.d. | |
6 d/PHA | + | + | + | n.d. | + | − | + | n.d. | n.d. | − | − | − | − | + | n.d. | n.d. | + | − | − | − | − | − | n.d. | n.d. |
In donors II and III repeated assessments were performed
(+) present, (−) absent, (+/−) trace expression, n.d. not determined